RE:RE:Average analysts’ price targetsThese are mostly stocks I own, and a few I follow. I have four times as much invested in Yangarra as Leucrotta. The CEO at Leucrotta has a great track record - he will build it up and likely sell to Tourmaline - worth researching. It is a slower play, but will be successful, almost guaranteed - wish they spent more time and money on the name and logo, but don't be fooled, it's run by serious people. I left surge off my list because I don't own it, but it's showing a 75% upside. I'm not a fan of when companies fill up over allotments (surge just did this). I find it kills hunger for the stock in the open market, as big investors often get filled up or over eat - same thing happened with LXE, but I was in on the equity raise and didn't want to back out even though I was disappointed they issued many more shares then they initially intended.
If yangarara stays put any longer, I will need to shuffle more into it - the upside compared to others keeps getting higher. It's difficult, because there are so many great opertunities. YGR ~51.74%, ARX 44.46%, and PXT 47.49% are probably my top picks right now. IMO and just sharing averages as I calculated them. Please do your own research.
Good luck to all investors - O and G shorts must be hurting and worried right now. It's funny that Covid will have made them a bunch of money because nobody knew it was coming, but the end of Covid will make them loose a bunch of money even though we all knew the end would eventually come.